Skip to main content
OncoTargets and Therapy logoLink to OncoTargets and Therapy
. 2017 May 31;10:2779–2780. doi: 10.2147/OTT.S140829

Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corrigendum]

PMCID: PMC5460650  PMID: 28615957

Ye T, Su J, Huang C, et al. OncoTargets Ther. 2016;9:7481–7492.

The authors have advised that a number of errors were made in some of the figures within their paper.

Page 7485, Figure 2A, the corrected image for PANC-1 protein AMPK is:

graphic file with name ott-10-2779Fig1.jpg

On page 7486, Figure 3 was incorrect. The correct figure is:

graphic file with name ott-10-2779Fig2.jpg

graphic file with name ott-10-2779Fig2a.jpg

Page 7487, Figure 4B, the corrected image for PATU-8988 protein MMP2 is:

graphic file with name ott-10-2779Fig3.jpg

Page 7488, Figure 4D, the corrected image for shRNA-PANC-1 protein N-cadherin is:

graphic file with name ott-10-2779Fig4.jpg

Page 7489, Figure 5A, Migration section, the corrected image for PATU-8988 at the concentration of Isoorientin-160 μM is:

graphic file with name ott-10-2779Fig5.jpg

Page 7490, Figure 5B, Migration section, the corrected image for shRNA-PATU-8988 is:

graphic file with name ott-10-2779Fig6.jpg


Articles from OncoTargets and therapy are provided here courtesy of Dove Press

RESOURCES